Pharmaceutical Manufacturer
Cost Recovery Through Price Increases
Strategic Pricing in Pharma: Recovering Costs Through Differentiated Price Adjustments
An $800M pharmaceutical manufacturer implemented a data-driven pricing model to offset rising costs, increasing profitability and market share.
Rising raw material costs and heavily negotiated long-term contracts created margin pressure for this $800M pharmaceutical manufacturer. With inconsistent discounting policies and wide variations in customer size and pricing structures, the company struggled to pass through cost increases effectively. To address these challenges, they implemented a differentiated pricing model, incorporating material costs, geography, and capacity utilization. By aligning pricing with value proposition and peer performance, the company achieved $100M in impact over four years, driving machine profitability and increasing wallet share.
Explore More Case Studies
Situation
Pricing Pressures in a Contract-Heavy Market
- Client raw material costs were experiencing massive increases
- Majority of revenue was tied to heavily-negotiated long-term agreements
- Inconsistent usage of discounting and freight policies
- Wide variation in customer size, where large customers had contracts but smaller were more transactional
- Cost trends revealed steep increases, where pass-through was not fully realized
- Experiencing shrinking margins due to increased costs and customer contracts
Approach
Optimizing Price Adjustments with Data-Driven Strategies
- Developed differentiated pricing model to capture price impact, with consideration to material cost, geography, and capacity utilization
- Instituted sales best practices to negotiate annual contracts based on value proposition and performance vs peers
- Crafted internal and external messaging for off-cycle pricing
Reduce Unmanaged Variation with Intentional Price Differentiation
Key Takeaway
- Differentiated price adjustments based on performance vs peers, with risk mitigation via caps and controls